1. Baraclude Prescribing Information. US Food and Drug Administration [Internet] (2012)
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=BARACLUDE
. Accessed 27 Jan 2013
2. Belatacept Prescribing Information (US FDA) [Internet] (2013)
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Label_ApprovalHistory#labelinfo
. Accessed 14 March 2013
3. Bifano M, Grasela D, Pfister, MP (2010) Quantitative modeling and simulation to optimize dosing in renally impaired patients: application to entecavir. Am Soc Nephrol 21:390A
4. Briasoulis A, Bakris GL (2013) Chronic kidney disease as a coronary artery disease risk equivalent. Curr Cardiol Rep 15(3):340
5. Bruchfeld A, Lindahl K, Schvarcz R, Ståhle L (2002) Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis. Ther Drug Monit 24(6):701–708